PICCIN, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.626
AS - Asia 1.279
EU - Europa 654
SA - Sud America 155
AF - Africa 24
OC - Oceania 4
Totale 4.742
Nazione #
US - Stati Uniti d'America 2.572
SG - Singapore 497
CN - Cina 372
DE - Germania 187
VN - Vietnam 140
BR - Brasile 124
UA - Ucraina 123
GB - Regno Unito 87
HK - Hong Kong 80
TR - Turchia 62
RU - Federazione Russa 44
IT - Italia 42
FI - Finlandia 39
FR - Francia 39
SE - Svezia 33
IN - India 28
CA - Canada 24
JP - Giappone 24
AR - Argentina 19
MX - Messico 17
BD - Bangladesh 14
BE - Belgio 12
PK - Pakistan 12
PL - Polonia 10
IQ - Iraq 9
ZA - Sudafrica 9
ES - Italia 8
NL - Olanda 8
ID - Indonesia 7
UZ - Uzbekistan 6
CZ - Repubblica Ceca 4
DZ - Algeria 4
JM - Giamaica 4
KZ - Kazakistan 4
LT - Lituania 4
PH - Filippine 4
AU - Australia 3
EC - Ecuador 3
IE - Irlanda 3
IR - Iran 3
JO - Giordania 3
NP - Nepal 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EG - Egitto 2
RO - Romania 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CO - Colombia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 4.742
Città #
Ashburn 523
Singapore 331
Woodbridge 277
Fairfield 164
San Jose 161
Jacksonville 140
Beijing 139
Houston 132
Chandler 131
Ann Arbor 99
Santa Clara 96
Hong Kong 79
Seattle 71
Wilmington 60
Cambridge 54
Addison 47
Dallas 46
Izmir 44
Ho Chi Minh City 39
Nanjing 38
Hanoi 36
Munich 33
Los Angeles 29
New York 28
Princeton 28
Milan 24
Lauterbourg 23
Tokyo 23
San Diego 22
Boardman 21
Shanghai 20
Dearborn 16
São Paulo 16
Orem 15
Shenyang 15
Mexico City 13
Montreal 12
Brussels 11
Da Nang 11
Hefei 11
Kunming 11
Chicago 10
Guangzhou 10
Warsaw 10
Brooklyn 9
Manchester 9
Turku 9
Haiphong 8
Hebei 8
Jiaxing 8
London 8
Nanchang 8
City of London 7
Jinan 7
Tianjin 7
Atlanta 6
Changsha 6
Denver 6
Johannesburg 6
Norwalk 6
San Mateo 6
Baghdad 5
Falkenstein 5
Lahore 5
Leawood 5
Mountain View 5
Redwood City 5
Tashkent 5
Washington 5
Amsterdam 4
Ankara 4
Boston 4
Brasília 4
Chennai 4
Des Moines 4
Falls Church 4
Hangzhou 4
Helsinki 4
Kingston 4
Paris 4
Porto Alegre 4
San Francisco 4
Tappahannock 4
Almaty 3
Amman 3
Buffalo 3
Campinas 3
Delhi 3
Dublin 3
Madrid 3
Monmouth Junction 3
Montréal 3
Moscow 3
Phoenix 3
Poplar 3
Stockholm 3
Thái Nguyên 3
Ardabil 2
Augusta 2
Baku 2
Totale 3.387
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 430
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 260
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 247
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 239
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 232
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 230
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Antiproliferative effects of somatostatin analogs in pituitary adenomas 200
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 200
miR-15a and miR-16-1 down-regulation in pituitary adenomas 193
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 176
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 170
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 161
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 158
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 155
Chemoresistance of Medullary thryroid carcinoma cells is reversed by COX-2 inhibitors in vitro through a PGE2-dependent mechanism 152
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 152
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 149
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 147
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 144
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 141
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone (GHRH)-secreting bronchial carcinoid 139
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 134
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 116
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 111
null 106
Totale 4.755
Categoria #
all - tutte 19.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 34 49 10
2021/2022330 10 41 31 6 18 12 17 11 10 21 33 120
2022/2023281 28 24 24 35 36 46 24 16 31 1 12 4
2023/2024405 16 28 3 5 12 26 6 273 4 1 0 31
2024/2025505 12 10 44 12 64 61 6 20 91 47 89 49
2025/20261.686 195 72 147 159 310 113 264 97 157 172 0 0
Totale 4.755